dihydroxyphenylalanine has been researched along with Adrenal Cancer in 81 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two patients with nonmetastatic adrenal pheochromocytoma, and 9 patients with extraadrenal abdominal paraganglioma (1 nonmetastatic, 8 metastatic), underwent whole-body CT, MRI, baseline (18)F-DOPA PET, and (18)F-DOPA PET with oral preadministration of 200 mg of carbidopa." | 9.12 | The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma. ( Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Hadi, M; Ling, A; Martiniova, L; Pacak, K; Timmers, HJ; Whatley, M, 2007) |
| "(18)F-fluorodihydroxyphenylalanine (FDOPA) is a powerful tool for the diagnosis and detection of neuroendocrine tumors when planning and monitoring surgical and oncologic therapies." | 8.90 | 18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors. ( Forsback, S; Kauhanen, S; Kemppainen, J; Minn, H; Seppänen, M, 2014) |
| "To evaluate (18)F-fluorodihydroxyphenylalanine-positron emission tomography/ contrast-enhanced computed tomography ((18)F-DOPA PET/CT) for the detection of paragangliomas (PARA) without any patient selection, such as genetic predisposition for the development of these tumors, history of metastatic PARA or hormonal status." | 7.83 | Clinical Value of 18F-fluorodihydroxyphenylalanine Positron Emission Tomography/Contrast-enhanced Computed Tomography (18F-DOPA PET/CT) in Patients with Suspected Paraganglioma. ( Dudczak, R; El-Rabadi, K; Hacker, M; Karanikas, G; Mayerhofer, M; Mitterhauser, M; Nakuz, T; Scherer, T; Weber, M, 2016) |
| "Pheochromocytomas (PHEOs) and paragangliomas (PGLs) may be better detected by (18)F-fluorodihydroxyphenylalanine-positron emission tomography (FDOPA-PET) than (123)I-metaiodobenzyl-guanidine (123-I-MIBG) scintigraphy." | 7.76 | 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transpo ( Anlauf, M; Bartenstein, P; Fottner, C; Helisch, A; Klöppel, G; Kreft, A; Lackner, KJ; Musholt, TJ; Rossmann, H; Schadmand-Fischer, S; Schreckenberger, M; Weber, MM, 2010) |
| "Flow-cytometric analysis of nuclear DNA and measurements of tissue levels of dihydroxyphenylalanine (dopa) and catecholamines were performed using fresh samples of tissue taken from 17 patients with pheochromocytoma." | 7.69 | Nuclear DNA ploidy pattern and tissue levels of dihydroxyphenylalanine and catecholamines in pheochromocytoma. ( Ishigooka, M; Kubota, Y; Nakada, T; Sasagawa, I; Sawamura, T; Suzuki, Y, 1995) |
| "In PC12 rat pheochromocytoma cells differentiated with nerve growth factor (NGF), neuropeptide Y inhibited depolarization-stimulated catecholamine synthesis as determined by in situ measurement of 3,4-dihydroxyphenylalanine (DOPA) production in the presence of the decarboxylase inhibitor m-hydroxybenzylhydrazine (NSD-1015)." | 7.69 | Neuropeptide Y inhibits depolarization-stimulated catecholamine synthesis in rat pheochromocytoma cells. ( McCullough, LA; Westfall, TC, 1995) |
| "A suppression of norepinephrine, epinephrine, and its metabolites in malignant pheochromocytoma by metyrosine was associated with an increase in tyrosine, plasma DOPA, and sulfate esters of DOPA and dopamine, followed, with continuing metyrosine administration, by a further rise of both DOPA sulfate and dopamine sulfate." | 7.68 | Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma. ( Buu, NT; Edwards, DJ; Kuchel, O, 1990) |
| "Effects of the 1-methyl-4-phenylpyridinium ion (MPP+) on DOPA formation and phosphorylation of tyrosine hydroxylase (TH) of rat pheochromocytoma PC12h cells were examined after the cells were cultured with MPP+." | 7.67 | Effect of the 1-methyl-4-phenylpyridinium ion on phosphorylation of tyrosine hydroxylase in rat pheochromocytoma PC12h cells. ( Hagiwara, M; Hidaka, H; Kiuchi, K; Nagatsu, T, 1988) |
| "Adenosine increases the activity of tyrosine 3-monooxygenase in intact pheochromocytoma cells." | 7.66 | Activation of tyrosine 3-monooxygenase in pheochromocytoma cells by adenosine. ( Berezo, MW; Erny, RE; Perlman, RL, 1981) |
| "The carboxylic ionophore monensin inhibits the activity of tyrosine 3-monooxygenase and decreases the rate of catecholamine synthesis in pheochromocytoma cells incubated in vitro." | 7.66 | Monensin inhibits catecholamine synthesis in pheochromocytoma cells. ( Liang, BT; Perlman, RL; Sheard, BE; Vaccaro, KK, 1982) |
| "Two patients with nonmetastatic adrenal pheochromocytoma, and 9 patients with extraadrenal abdominal paraganglioma (1 nonmetastatic, 8 metastatic), underwent whole-body CT, MRI, baseline (18)F-DOPA PET, and (18)F-DOPA PET with oral preadministration of 200 mg of carbidopa." | 5.12 | The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma. ( Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Hadi, M; Ling, A; Martiniova, L; Pacak, K; Timmers, HJ; Whatley, M, 2007) |
| "(18)F-fluorodihydroxyphenylalanine (FDOPA) is a powerful tool for the diagnosis and detection of neuroendocrine tumors when planning and monitoring surgical and oncologic therapies." | 4.90 | 18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors. ( Forsback, S; Kauhanen, S; Kemppainen, J; Minn, H; Seppänen, M, 2014) |
| "To evaluate (18)F-fluorodihydroxyphenylalanine-positron emission tomography/ contrast-enhanced computed tomography ((18)F-DOPA PET/CT) for the detection of paragangliomas (PARA) without any patient selection, such as genetic predisposition for the development of these tumors, history of metastatic PARA or hormonal status." | 3.83 | Clinical Value of 18F-fluorodihydroxyphenylalanine Positron Emission Tomography/Contrast-enhanced Computed Tomography (18F-DOPA PET/CT) in Patients with Suspected Paraganglioma. ( Dudczak, R; El-Rabadi, K; Hacker, M; Karanikas, G; Mayerhofer, M; Mitterhauser, M; Nakuz, T; Scherer, T; Weber, M, 2016) |
| "To evaluate the clinical value of (18) F-fluorodihydroxyphenylalanine ((18) F-FDOPA) PET in relation to tumour localization and the patient's genetic status in a large series of pheochromocytoma/paraganglioma (PHEO/PGL) patients and to discuss in detail false-negative results." | 3.79 | Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions. ( Barlier, A; Blanchet, EM; Chen, CC; Deveze, A; Fakhry, N; Gabriel, S; Morange, I; Pacak, K; Sebag, F; Taïeb, D, 2013) |
| "To define the appropriate scan time for fluorine-18-labeled dihydroxyphenylalanine (F-18 DOPA) PET in oncological imaging of pheochromocytomas and paragangliomas." | 3.78 | Is there an optimal scan time for 6-[F-18]fluoro-L-DOPA PET in pheochromocytomas and paragangliomas? ( Boedeker, CC; Brink, I; Hentschel, M; Neumann, HP; Rottenburger, C, 2012) |
| "Pheochromocytomas (PHEOs) and paragangliomas (PGLs) may be better detected by (18)F-fluorodihydroxyphenylalanine-positron emission tomography (FDOPA-PET) than (123)I-metaiodobenzyl-guanidine (123-I-MIBG) scintigraphy." | 3.76 | 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transpo ( Anlauf, M; Bartenstein, P; Fottner, C; Helisch, A; Klöppel, G; Kreft, A; Lackner, KJ; Musholt, TJ; Rossmann, H; Schadmand-Fischer, S; Schreckenberger, M; Weber, MM, 2010) |
| "Besides (123)I-metaiodobenzylguanidine (MIBG), positron emission tomography (PET) agents are available for the localization of paraganglioma (PGL), including (18)F-3,4-dihydroxyphenylalanine (DOPA), (18)F-fluoro-2-deoxy-D-glucose ((18)F-FDG), and (18)F-fluorodopamine ((18)F-FDA)." | 3.75 | Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. ( Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Havekes, B; Ling, A; Martiniova, L; Pacak, K; Timmers, HJ; Whatley, M, 2009) |
| "To evaluate fluorine 18 ((18)F) dihydroxyphenylalanine (DOPA) whole-body positron emission tomography (PET) as a biochemical imaging approach for detection of pheochromocytomas." | 3.71 | Pheochromocytomas: detection with 18F DOPA whole body PET--initial results.. ( Altehoefer, C; Brink, I; Ghanem, N; Hoegerle, S; Manz, T; Moser, E; Neumann, HP; Nitzsche, E; Reincke, M, 2002) |
| "Flow-cytometric analysis of nuclear DNA and measurements of tissue levels of dihydroxyphenylalanine (dopa) and catecholamines were performed using fresh samples of tissue taken from 17 patients with pheochromocytoma." | 3.69 | Nuclear DNA ploidy pattern and tissue levels of dihydroxyphenylalanine and catecholamines in pheochromocytoma. ( Ishigooka, M; Kubota, Y; Nakada, T; Sasagawa, I; Sawamura, T; Suzuki, Y, 1995) |
| "In PC12 rat pheochromocytoma cells differentiated with nerve growth factor (NGF), neuropeptide Y inhibited depolarization-stimulated catecholamine synthesis as determined by in situ measurement of 3,4-dihydroxyphenylalanine (DOPA) production in the presence of the decarboxylase inhibitor m-hydroxybenzylhydrazine (NSD-1015)." | 3.69 | Neuropeptide Y inhibits depolarization-stimulated catecholamine synthesis in rat pheochromocytoma cells. ( McCullough, LA; Westfall, TC, 1995) |
| "A suppression of norepinephrine, epinephrine, and its metabolites in malignant pheochromocytoma by metyrosine was associated with an increase in tyrosine, plasma DOPA, and sulfate esters of DOPA and dopamine, followed, with continuing metyrosine administration, by a further rise of both DOPA sulfate and dopamine sulfate." | 3.68 | Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma. ( Buu, NT; Edwards, DJ; Kuchel, O, 1990) |
| "Vasoactive intestinal peptide (VIP) acutely increases tyrosine hydroxylase (TH) activity in cultures of dispersed normal adult rat chromaffin cells and of PC12 rat pheochromocytoma cells." | 3.67 | Vasoactive intestinal peptide increases tyrosine hydroxylase activity in normal and neoplastic rat chromaffin cell cultures. ( Costopoulos, D; Horwitz, J; Perlman, RL; Tischler, AS, 1985) |
| "Effects of the 1-methyl-4-phenylpyridinium ion (MPP+) on DOPA formation and phosphorylation of tyrosine hydroxylase (TH) of rat pheochromocytoma PC12h cells were examined after the cells were cultured with MPP+." | 3.67 | Effect of the 1-methyl-4-phenylpyridinium ion on phosphorylation of tyrosine hydroxylase in rat pheochromocytoma PC12h cells. ( Hagiwara, M; Hidaka, H; Kiuchi, K; Nagatsu, T, 1988) |
| "Adenosine increases the activity of tyrosine 3-monooxygenase in intact pheochromocytoma cells." | 3.66 | Activation of tyrosine 3-monooxygenase in pheochromocytoma cells by adenosine. ( Berezo, MW; Erny, RE; Perlman, RL, 1981) |
| "The carboxylic ionophore monensin inhibits the activity of tyrosine 3-monooxygenase and decreases the rate of catecholamine synthesis in pheochromocytoma cells incubated in vitro." | 3.66 | Monensin inhibits catecholamine synthesis in pheochromocytoma cells. ( Liang, BT; Perlman, RL; Sheard, BE; Vaccaro, KK, 1982) |
| "Paragangliomas are tumours that arise within the sympathetic nervous system originating from the neural crest." | 2.43 | Imaging of pheochromocytoma and paraganglioma. ( Bley, TA; Brink, I; Hoegerle, S; Klisch, J, 2005) |
| "Pheochromocytoma is a rare but clinically important tumor of catecholamine-secreting chromaffin cells." | 2.41 | Diagnostic localization of pheochromocytoma: the coming of age of positron emission tomography. ( Carrasquillo, JA; Chen, CC; Eisenhofer, G; Goldstein, DS; Pacak, K; Whatley, M, 2002) |
| "All pheochromocytomas were detected by both PET/CT and MRI." | 1.40 | (18)F-DOPA PET/CT and MRI: description of 12 histologically-verified pheochromocytomas. ( Dudczak, R; Hacker, M; Javor, D; Karanikas, G; Khameneh, A; Magnaldi, S; Mayerhoefer, ME; Mitterhauser, M; Schuetz, M, 2014) |
| "Paragangliomas and pheochromocytomas are genetically heterogeneous diseases." | 1.38 | Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET. ( Benz, MR; Campbell, D; Dumont, RA; Mix, M; Neumann, HP; Rischke, HC; Rössler, J; Seufert, J; Weber, WA; Wiech, T; Wild, D, 2012) |
| "Successful treatment of pheochromocytoma requires accurate diagnosis and localization of tumors." | 1.35 | 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas. ( Agopian, VG; Auerbach, MS; Benz, MR; Czernin, JG; Dumont, RA; Imani, F; Lai, CK; Walter, MA; Yeh, MW, 2009) |
| "Neuroblastoma was the most common cause of elevated dopamine in children's specimens, although other associations are described." | 1.33 | Elevated urinary dopamine in adults and children. ( Davidson, DF, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (23.46) | 18.7374 |
| 1990's | 10 (12.35) | 18.2507 |
| 2000's | 19 (23.46) | 29.6817 |
| 2010's | 30 (37.04) | 24.3611 |
| 2020's | 3 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Cottereau, AS | 1 |
| Garcia, C | 1 |
| Dousset, B | 1 |
| Libe, R | 1 |
| Tenenbaum, F | 2 |
| Goujon, A | 1 |
| Pop, G | 1 |
| Hissier, J | 1 |
| Moreau, B | 1 |
| Palard-Novello, X | 1 |
| Wei, F | 1 |
| Wu, B | 1 |
| Ling, X | 1 |
| Gong, J | 1 |
| Xu, H | 1 |
| Rotania, M | 1 |
| Chabrier, G | 1 |
| Imperiale, A | 2 |
| Moreau, A | 2 |
| Giraudet, AL | 2 |
| Kryza, D | 2 |
| Borson-Chazot, F | 2 |
| Bournaud-Salinas, C | 1 |
| Mognetti, T | 2 |
| Lifante, JC | 2 |
| Combemale, P | 2 |
| Giammarile, F | 2 |
| Houzard, C | 2 |
| Bournaud, C | 1 |
| Taïeb, D | 7 |
| Jha, A | 1 |
| Guerin, C | 3 |
| Pang, Y | 1 |
| Adams, KT | 4 |
| Chen, CC | 6 |
| Romanet, P | 1 |
| Roche, P | 1 |
| Essamet, W | 1 |
| Ling, A | 3 |
| Quezado, MM | 1 |
| Castinetti, F | 2 |
| Sebag, F | 5 |
| Pacak, K | 12 |
| Berends, AMA | 1 |
| Kerstens, MN | 2 |
| Bolt, JW | 1 |
| Links, TP | 2 |
| Korpershoek, E | 1 |
| de Krijger, RR | 1 |
| Walenkamp, AME | 1 |
| Noordzij, W | 1 |
| van Etten, B | 1 |
| Kats-Ugurlu, G | 1 |
| Brouwers, AH | 3 |
| van der Horst-Schrivers, ANA | 1 |
| Moog, S | 1 |
| Houy, S | 1 |
| Chevalier, E | 1 |
| Ory, S | 1 |
| Weryha, G | 1 |
| Rame, M | 1 |
| Klein, M | 1 |
| Brunaud, L | 1 |
| Gasman, S | 1 |
| Cuny, T | 1 |
| Lugat, A | 1 |
| Drui, D | 1 |
| Mirallié, E | 1 |
| Kraeber-Bodéré, F | 1 |
| Ansquer, C | 1 |
| Marzola, MC | 1 |
| Chondrogiannis, S | 1 |
| Grassetto, G | 1 |
| Rampin, L | 1 |
| Maffione, AM | 1 |
| Ferretti, A | 2 |
| Opocher, G | 1 |
| Schiavi, F | 1 |
| Colletti, PM | 2 |
| Rubello, D | 2 |
| Blanchet, EM | 2 |
| Martucci, V | 1 |
| Millo, C | 1 |
| Herscovitch, P | 1 |
| Bacca, A | 1 |
| Chiacchio, S | 1 |
| Zampa, V | 1 |
| Carrara, D | 1 |
| Duce, V | 1 |
| Congregati, C | 1 |
| Simi, P | 1 |
| Taddei, S | 1 |
| Materazzi, G | 1 |
| Volterrani, D | 1 |
| Mariani, G | 1 |
| Bernini, G | 1 |
| Magnaldi, S | 1 |
| Mayerhoefer, ME | 1 |
| Khameneh, A | 1 |
| Schuetz, M | 1 |
| Javor, D | 1 |
| Mitterhauser, M | 2 |
| Dudczak, R | 2 |
| Hacker, M | 2 |
| Karanikas, G | 2 |
| Timmers, HJ | 3 |
| Shulkin, BL | 1 |
| Minn, H | 1 |
| Kemppainen, J | 1 |
| Kauhanen, S | 1 |
| Forsback, S | 1 |
| Seppänen, M | 1 |
| Santhanam, P | 1 |
| Shamim, SA | 1 |
| Kumar, A | 1 |
| Kumar, R | 1 |
| Paladino, NC | 1 |
| Lowery, A | 1 |
| Archier, A | 1 |
| Varoquaux, A | 1 |
| Garrigue, P | 1 |
| Montava, M | 1 |
| Gabriel, S | 2 |
| Beschmout, E | 1 |
| Morange, I | 3 |
| Fakhry, N | 2 |
| Barlier, A | 3 |
| Loundou, A | 1 |
| Guillet, B | 1 |
| Heimburger, C | 1 |
| Averous, G | 1 |
| Charlin, E | 1 |
| Lang, H | 1 |
| Kurtz, JE | 1 |
| El-Rabadi, K | 1 |
| Weber, M | 1 |
| Mayerhofer, M | 1 |
| Nakuz, T | 1 |
| Scherer, T | 1 |
| Mazza, A | 1 |
| Sacco, AP | 1 |
| Fiebrich, HB | 2 |
| van Bergeijk, L | 1 |
| van den Berg, G | 1 |
| Imani, F | 2 |
| Agopian, VG | 1 |
| Auerbach, MS | 1 |
| Walter, MA | 1 |
| Benz, MR | 2 |
| Dumont, RA | 2 |
| Lai, CK | 1 |
| Czernin, JG | 1 |
| Yeh, MW | 1 |
| Pijl, ME | 1 |
| Kema, IP | 1 |
| de Jong, JR | 1 |
| Jager, PL | 1 |
| Elsinga, PH | 1 |
| Dierckx, RA | 1 |
| van der Wal, JE | 1 |
| Sluiter, WJ | 1 |
| de Vries, EG | 1 |
| Martiniova, L | 4 |
| Lai, EW | 3 |
| Thomasson, D | 2 |
| Kiesewetter, DO | 2 |
| Seidel, J | 2 |
| Merino, MJ | 1 |
| Kvetnansky, R | 2 |
| Carrasquillo, JA | 3 |
| Whatley, M | 3 |
| Havekes, B | 1 |
| Eisenhofer, G | 7 |
| Chew, SL | 1 |
| Fottner, C | 1 |
| Helisch, A | 1 |
| Anlauf, M | 1 |
| Rossmann, H | 1 |
| Musholt, TJ | 1 |
| Kreft, A | 1 |
| Schadmand-Fischer, S | 1 |
| Bartenstein, P | 1 |
| Lackner, KJ | 1 |
| Klöppel, G | 1 |
| Schreckenberger, M | 1 |
| Weber, MM | 1 |
| Grassi, I | 1 |
| Nanni, C | 1 |
| Vicennati, V | 1 |
| Castellucci, P | 1 |
| Allegri, V | 1 |
| Montini, GC | 1 |
| Pagotto, U | 1 |
| di Dalmazi, G | 1 |
| Pasquali, R | 1 |
| Fanti, S | 2 |
| Rufini, V | 2 |
| Treglia, G | 2 |
| Castaldi, P | 2 |
| Perotti, G | 1 |
| Calcagni, ML | 1 |
| Corsello, SM | 1 |
| Galli, G | 1 |
| Giordano, A | 1 |
| Levine, DS | 1 |
| Metzger, DL | 1 |
| Nadel, HR | 1 |
| Oviedo, A | 1 |
| Adam, MJ | 1 |
| Skarsgard, E | 1 |
| Cleary, S | 1 |
| Dawson, LF | 1 |
| Phillips, JK | 1 |
| Chen, X | 1 |
| Powers, JF | 1 |
| Hentschel, M | 1 |
| Rottenburger, C | 1 |
| Boedeker, CC | 1 |
| Neumann, HP | 3 |
| Brink, I | 3 |
| Rischke, HC | 1 |
| Wild, D | 1 |
| Mix, M | 1 |
| Campbell, D | 1 |
| Seufert, J | 1 |
| Wiech, T | 1 |
| Rössler, J | 1 |
| Weber, WA | 1 |
| Deveze, A | 1 |
| Goldstein, DS | 4 |
| GJESSING, LR | 2 |
| Eldadah, BA | 1 |
| Holmes, C | 1 |
| Kopin, IJ | 1 |
| Sullivan, P | 1 |
| Csako, G | 1 |
| Brouwers, FM | 1 |
| Hoegerle, S | 2 |
| Klisch, J | 1 |
| Bley, TA | 1 |
| Davidson, DF | 1 |
| Yatabe, J | 1 |
| Sanada, H | 1 |
| Seshadri, N | 1 |
| Wat, J | 1 |
| Balan, K | 1 |
| Hadi, M | 1 |
| Mackenzie, IS | 1 |
| Gurnell, M | 1 |
| Balan, KK | 1 |
| Simpson, H | 1 |
| Chatterjee, K | 1 |
| Brown, MJ | 1 |
| Seibyl, JP | 1 |
| Chen, W | 1 |
| Silverman, DH | 1 |
| Tessonnier, L | 1 |
| Niccoli-Sire, P | 1 |
| Colavolpe, C | 1 |
| De Micco, C | 1 |
| Palazzo, FF | 1 |
| Henry, JF | 1 |
| Mundler, O | 1 |
| Erny, RE | 1 |
| Berezo, MW | 1 |
| Perlman, RL | 5 |
| Vaccaro, KK | 1 |
| Liang, BT | 1 |
| Sheard, BE | 2 |
| Tischler, AS | 3 |
| Morse, GM | 1 |
| Majeswka, Z | 1 |
| Wocial, B | 3 |
| McClean, DR | 1 |
| Sinclair, LM | 1 |
| Yandle, TG | 1 |
| Nicholls, MG | 1 |
| Sasagawa, I | 1 |
| Nakada, T | 1 |
| Kubota, Y | 1 |
| Ishigooka, M | 1 |
| Sawamura, T | 1 |
| Suzuki, Y | 1 |
| Newcomer, TA | 1 |
| Rosenberg, PA | 1 |
| Aizenman, E | 1 |
| Anastasiadis, PZ | 1 |
| States, JC | 1 |
| Kuhn, DM | 1 |
| Levine, RA | 1 |
| McCullough, LA | 1 |
| Westfall, TC | 1 |
| Januszewicz, W | 2 |
| Gryglas, P | 1 |
| Januszewicz, A | 1 |
| Feltynowski, T | 1 |
| Lapiński, M | 1 |
| Gavrilenko, AV | 1 |
| Sheremet'eva, GF | 1 |
| Skrylev, SI | 1 |
| Zolicheva, NIu | 1 |
| Lisitskiĭ, DA | 1 |
| Siniavin, GV | 1 |
| Nitzsche, E | 1 |
| Altehoefer, C | 1 |
| Ghanem, N | 1 |
| Manz, T | 1 |
| Reincke, M | 1 |
| Moser, E | 1 |
| Ishii, A | 1 |
| Kiuchi, K | 2 |
| Kobayashi, R | 1 |
| Sumi, M | 1 |
| Hidaka, H | 2 |
| Nagatsu, T | 3 |
| Maruyama, W | 1 |
| Minami, M | 1 |
| Ota, A | 1 |
| Takahashi, T | 1 |
| Takahashi, A | 1 |
| Naoi, M | 1 |
| Kuchel, O | 1 |
| Buu, NT | 1 |
| Edwards, DJ | 1 |
| Ruzicka, LA | 1 |
| Shigetomi, S | 1 |
| Roskoski, R | 1 |
| White, L | 1 |
| Knowlton, R | 1 |
| Roskoski, LM | 1 |
| Costopoulos, D | 1 |
| Horwitz, J | 1 |
| Hagiwara, M | 1 |
| Stull, R | 1 |
| Sisson, JC | 1 |
| Weder, A | 1 |
| Averbuch, SD | 1 |
| Keiser, HR | 2 |
| Bräutigam, M | 1 |
| Laschinski, G | 1 |
| Kittner, B | 1 |
| Herken, H | 1 |
| Atkins, FL | 1 |
| Beaven, MA | 1 |
| Käser, H | 1 |
| Wagner, HP | 1 |
| Zuppinger, K | 1 |
| Zurbrügg, R | 1 |
| Louis, WJ | 1 |
| Doyle, AE | 1 |
| Heath, WC | 1 |
| Robinson, MJ | 2 |
| Kent, M | 1 |
| Stocks, J | 1 |
| Sullivan, JM | 1 |
| Delacretaz, J | 1 |
| Emch, M | 1 |
| Schellhorn, JP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Diagnosis, Pathophysiology, and Molecular Biology of Pheochromocytoma and Paraganglioma[NCT00004847] | Phase 1 | 3,000 participants (Anticipated) | Interventional | 2000-03-22 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for dihydroxyphenylalanine and Adrenal Cancer
| Article | Year |
|---|---|
18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors.
Topics: Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Intestinal Neopl | 2014 |
Role of (18) F-FDOPA PET/CT imaging in endocrinology.
Topics: Adrenal Gland Neoplasms; Carbidopa; Carcinoid Tumor; Carcinoma, Neuroendocrine; Dihydroxyphenylalani | 2014 |
PET/Computed Tomography in Neuroendocrine Tumor: Value to Patient Management and Survival Outcomes.
Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gast | 2015 |
[Adrenal incidentaloma and nuclear medicine examination].
Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasm | 2009 |
Diagnostic localization of pheochromocytoma: the coming of age of positron emission tomography.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorine Radioisotopes; Huma | 2002 |
Imaging of pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Huma | 2005 |
[3,4-Dihydroxyphenyl alanine (DOPA)].
Topics: Adrenal Gland Neoplasms; Biomarkers; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; H | 2005 |
3,4-dihydroxy-6-[18f]-fluoro-L-phenylalanine positron emission tomography in patients with central motor disorders and in evaluation of brain and other tumors.
Topics: Adrenal Gland Neoplasms; Amino Acids; Brain Neoplasms; Caudate Nucleus; Dihydroxyphenylalanine; Fluo | 2007 |
[Pheochromocytoma].
Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Epinephrine; Humans; Norepinephrine; Pheochromocyto | 1982 |
3 trials available for dihydroxyphenylalanine and Adrenal Cancer
| Article | Year |
|---|---|
Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; False Positive Reac | 2016 |
The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma.
Topics: Abdominal Neoplasms; Adrenal Gland Neoplasms; Carbidopa; Dihydroxyphenylalanine; Female; Humans; Ima | 2007 |
[Evaluation of the usefulness for measuring catecholamines and their principle metabolites in the diagnosis of pheochromocytoma].
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Catecholamines; Dihydroxyphenylalanine; Dop | 1997 |
69 other studies available for dihydroxyphenylalanine and Adrenal Cancer
| Article | Year |
|---|---|
Recurrence of a Pheochromocytoma With TNEM127 Mutation Negative on 18F-FDOPA and 18F-FDG but Positive on 123I-MIBG and 68Ga-DOTATOC Imaging.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aged; Dihydroxyphenylalanine; Female; Fluorodeoxyglu | 2022 |
18 F-FDOPA PET/CT of Paraganglioma in the Spermatic Cord.
Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Humans; Male; Middle Aged; Paraganglioma; Positron | 2023 |
Comparison of 18 F-FDOPA and 18 F-MFBG PET/CT Images of Metastatic Pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Humans; Male; Neoplasms, Second Primary; Per | 2023 |
Synchronous bilateral pheochromocytomas and bilobar medullary thyroid carcinoma revealed by
Topics: Adrenal Gland Neoplasms; Adult; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; M | 2019 |
FDOPA Patterns in Adrenal Glands: A Pictorial Essay.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Aged; Dihydroxyphenylalanine; Female; Fluorine Radioisotope | 2017 |
Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT: focus on pheochromocytomas.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Diagnosis, Differential; Dihydroxyphenylalan | 2017 |
18F-FDOPA PET/CT Imaging of MAX-Related Pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Dihydro | 2018 |
False-positive findings on 6-[18F]fluor-l-3,4-dihydroxyphenylalanine PET (
Topics: Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; False Positive Reactions; Female; Huma | 2018 |
18F-FDOPA PET/CT Uptake Parameters Correlate with Catecholamine Secretion in Human Pheochromocytomas.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Catecholamines; Dihydroxyphenylalanine; Female; Humans; Male; | 2018 |
18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Huma | 2019 |
18F-DOPA PET/CT in the evaluation of hereditary SDH-deficiency paraganglioma-pheochromocytoma syndromes.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Female; Humans; Male; Middle Age | 2014 |
Multitracer PET imaging of bone metastases from paraganglioma: peripheral halo of uptake on 18F-FLT PET mismatching with central uptake of 18F-FDOPA, 18F-fluorodopamine, and 18F-FDG.
Topics: Adrenal Gland Neoplasms; Aged; Biological Transport; Bone Neoplasms; Dideoxynucleosides; Dihydroxyph | 2013 |
Role of 18F-DOPA PET/CT in diagnosis and follow-up of adrenal and extra-adrenal paragangliomas.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Female; Follow-Up Studies; | 2014 |
(18)F-DOPA PET/CT and MRI: description of 12 histologically-verified pheochromocytomas.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans | 2014 |
Renaissance of (18)F-FDG positron emission tomography in the imaging of pheochromocytoma/paraganglioma.
Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; History, 20th Century; Hist | 2014 |
Multimodality imaging of bilateral pheochromocytoma. A case report.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Aged; Dihydroxyphenylalanine; False N | 2015 |
Adrenal Metastasis of a Poorly Differentiated Adenocarcinoma Mimicking a Pheochromocytoma on 18F-FDOPA PET/CT.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adult; Diagnosis, Differential; Dihydroxyphenylalanine; Fat | 2016 |
Clinical Value of 18F-fluorodihydroxyphenylalanine Positron Emission Tomography/Contrast-enhanced Computed Tomography (18F-DOPA PET/CT) in Patients with Suspected Paraganglioma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; False Negative Reactions; Female; Huma | 2016 |
Catecholamine-Induced Chest Pain Mimicking Infarction Due to an MIBG-Negative and DOPA-Positive Succinate Dehydrogenase Syndrome Subunit B-Related Pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Catecholamines; Chest Pain; Dihydroxyphe | 2017 |
Image in endocrinology. Localization of an adrenocorticotropin-producing pheochromocytoma using 18F-dihydroxyphenylalanine positron emission tomography.
Topics: Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aged; Dihydroxyphenylalanine; Humans; Male; Ph | 2009 |
18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Female; Humans; Image Enhancement; Mal | 2009 |
6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine exces
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Biomarkers; | 2009 |
Animal model of metastatic pheochromocytoma: evaluation by MRI and PET.
Topics: Adrenal Gland Neoplasms; Animals; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Female; | 2009 |
Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Dop | 2009 |
Diagnosis: imaging of pheochromocytomas and paragangliomas.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Contrast Media; Diagnostic Imaging; Dihydroxyphenyla | 2010 |
6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transpo
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Biomarkers; Data Interpreta | 2010 |
I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; False Negative Reacti | 2011 |
Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Female; Humans; | 2011 |
Novel use of F-DOPA PET/CT imaging in a child with paraganglioma/pheochromocytoma syndrome.
Topics: Adolescent; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Female; Humans; Kidney Neoplasms; Multi | 2011 |
Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Animals; Contrast Media; Dihydroxyphenylalanine; Dopamine; Female; Liver Ne | 2012 |
Is there an optimal scan time for 6-[F-18]fluoro-L-DOPA PET in pheochromocytomas and paragangliomas?
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; | 2012 |
Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Biological Transport; Child; Di | 2012 |
(18)F-DOPA PET/CT revealed synchronous neuroendocrine tumors in two sisters with MEN2A syndrome.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; | 2013 |
Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions.
Topics: Abdominal Neoplasms; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; False Negative Reactions; Head | 2013 |
STUDIES OF FUNCTIONAL NEURAL TUMORS. V. URINARY EXCRETION OF 3-METHOXY-4HYDROXYPHENYL-LACTIC ACID.
Topics: Acetates; Adrenal Gland Neoplasms; Butyrates; Carcinoid Tumor; Child; Chromatography; Dihydroxypheny | 1963 |
STUDIES OF FUNCTIONAL NEURAL TUMORS. VI. BIOCHEMICAL DIAGNOSIS.
Topics: Abdominal Neoplasms; Adolescent; Adrenal Gland Neoplasms; Amino Acids; Child; Dihydroxyphenylalanine | 1964 |
Cardiac uptake-1 inhibition by high circulating norepinephrine levels in patients with pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Binding, Competitive; Dihydroxyphenylalanin | 2004 |
Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine.
Topics: Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Dopamine; Female; Humans; Male; Middle Aged; | 2005 |
Elevated urinary dopamine in adults and children.
Topics: Adrenal Gland Neoplasms; Adult; Antidepressive Agents; Catecholamines; Child; Dihydroxyphenylalanine | 2005 |
Bilateral adrenal metastases from malignant melanoma: concordant findings on (18)F-FDG and (18)F-FDOPA PET.
Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Mid | 2006 |
The use of 18-fluoro-dihydroxyphenylalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine-negative phaeochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Fluorine Radioisotope | 2007 |
The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Disease Progres | 2008 |
Activation of tyrosine 3-monooxygenase in pheochromocytoma cells by adenosine.
Topics: 2-Chloroadenosine; Adenosine; Adrenal Gland Neoplasms; Calcium; Cholera Toxin; Cyclic AMP; Dihydroxy | 1981 |
Monensin inhibits catecholamine synthesis in pheochromocytoma cells.
Topics: Adrenal Gland Neoplasms; Animals; Catecholamines; Cells, Cultured; Chromaffin Granules; Dihydroxyphe | 1982 |
Glucocorticoids increase catecholamine synthesis and storage in PC12 pheochromocytoma cell cultures.
Topics: Adrenal Gland Neoplasms; Animals; Cell Line; Cholera Toxin; Corticosterone; Dexamethasone; Dihydroxy | 1983 |
Malignant phaeochromocytoma with high circulating DOPA, and clonidine-suppressible noradrenaline.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Agonists; Aged; Clonidine; Dihydroxyphenylalanine; Humans; | 1995 |
Nuclear DNA ploidy pattern and tissue levels of dihydroxyphenylalanine and catecholamines in pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Catecholamines; Cell Nucleus; Chromatography, High Pressure Li | 1995 |
TOPA quinone, a kainate-like agonist and excitotoxin is generated by a catecholaminergic cell line.
Topics: Adrenal Gland Neoplasms; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Catecholamines; Chro | 1995 |
Co-induction of tetrahydrobiopterin (BH4) levels and tyrosine hydroxylase activity in cultured PC12 cells.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenal Gland Neoplasms; Analysis of Variance; Animals; Biopterins; | 1993 |
Neuropeptide Y inhibits depolarization-stimulated catecholamine synthesis in rat pheochromocytoma cells.
Topics: Adrenal Gland Neoplasms; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aro | 1995 |
[Surgical treatment of a patient with giant pheochromocytoma].
Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Dopamine; Epinephrine; Female; Humans; Middle Aged; | 2001 |
Pheochromocytomas: detection with 18F DOPA whole body PET--initial results..
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Female; Fluorine Radioisot | 2002 |
A selective Ca2+/calmodulin-dependent protein kinase II inhibitor, KN-62, inhibits the enhanced phosphorylation and the activation of tyrosine hydroxylase by 56 mM K+ in rat pheochromocytoma PC12h cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adrenal Gland Neoplasms; Animals; Calcium-Calmodulin- | 1991 |
Reduction of enzymatic activity of tyrosine hydroxylase by a heterocyclic amine, 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole (Trp-P-1), was due to reduced affinity to a cofactor biopterin.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenal Gland Neoplasms; Animals; Biopterins; Carbolines; Cell Line; | 1991 |
Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma.
Topics: Adrenal Gland Neoplasms; alpha-Methyltyrosine; Catecholamines; Dihydroxyphenylalanine; Dopamine; Epi | 1990 |
Mimicry and inhibition of nerve growth factor effects: interactions of staurosporine, forskolin, and K252a in PC12 cells and normal rat chromaffin cells in vitro.
Topics: Adrenal Gland Neoplasms; Adrenal Medulla; Alkaloids; Animals; Animals, Newborn; Axons; Carbazoles; C | 1990 |
[Clinical significance of 3,4-dihydroxyphenylalanine analysis in endocrine tests of the adrenal medulla and sympathetic nervous system].
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenal Medulla; Adult; Aged; Child; Child, Preschool; Chromato | 1989 |
Regulation of tyrosine hydroxylase activity in rat PC12 cells by neuropeptides of the secretin family.
Topics: Adrenal Gland Neoplasms; Animals; Calcium; Colforsin; Cyclic AMP; Dihydroxyphenylalanine; Enzyme Act | 1989 |
Vasoactive intestinal peptide increases tyrosine hydroxylase activity in normal and neoplastic rat chromaffin cell cultures.
Topics: Adrenal Gland Neoplasms; Adrenal Medulla; Animals; Cell Line; Cells, Cultured; Cyclic AMP; Dihydroxy | 1985 |
Effect of the 1-methyl-4-phenylpyridinium ion on phosphorylation of tyrosine hydroxylase in rat pheochromocytoma PC12h cells.
Topics: 1-Methyl-4-phenylpyridinium; Adrenal Gland Neoplasms; Animals; Dihydroxyphenylalanine; Pheochromocyt | 1988 |
Plasma 3,4-dihydroxyphenylalanine (dopa) and catecholamines in neuroblastoma or pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Catecholamines; Chromatography, High Pressure Liquid; Dihydroxyphenylalanin | 1986 |
Effect of apomorphine, alpha-methylparatyrosine, haloperidol and reserpine on DOPA production in clonal cell lines (PC-12 and N1E-115).
Topics: Adrenal Gland Neoplasms; alpha-Methyltyrosine; Animals; Apomorphine; Cell Line; Dihydroxyphenylalani | 1985 |
Clinical and biochemical aspects of pheochromocytoma. Report of 110 cases.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Child; Circadian Rhythm; Dihydroxyphenylalanine; D | 1985 |
Dopa decarboxylase in medullary carcinoma of the thyroid.
Topics: Adrenal Gland Neoplasms; Amine Oxidase (Copper-Containing); Aromatic Amino Acid Decarboxylase Inhibi | 1973 |
[Biochemical tumor diagnosis in childhood].
Topics: Adenoma, Islet Cell; Adrenal Gland Neoplasms; Carcinoma, Hepatocellular; Child; Cushing Syndrome; De | 1974 |
Secretion of dopa in phaeochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Dopamine; Epinephrine; Female; H | 1972 |
Phaeochromocytoma in childhood: report of 3 cases.
Topics: Adolescent; Adrenal Gland Neoplasms; Blood Pressure; Catecholamines; Child; Dihydroxyphenylalanine; | 1973 |
Pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenal Medulla; Catecholamines; Chromaffin System; Dihydroxyphenylalanine; | 1972 |
[Distribution of DL-3 (3,4-dihydroxyphenyl)-alanine-2 C14 in the organism of mice with Cloudmann's S91 melanoma].
Topics: Adrenal Gland Neoplasms; Animals; Carbon Isotopes; Computers; Dihydroxyphenylalanine; Isocarboxazid; | 1970 |